Literature DB >> 6965973

Endogenous pyrogens made by rabbit peritoneal exudate cells are identical with lymphocyte-activating factors made by rabbit alveolar macrophages.

P A Murphy, P L Simon, W F Willoughby.   

Abstract

Purified endogenous pyrogen (EP), isolated in one laboratory from stimulated rabbit peritoneal exudate cells (PEC), was compared with purified lymphocyte activating factor (LAF), isolated in another laboratory from stimulated rabbit alveolar macrophages (AM). Both EP and LAF occurred in two forms, one with an isoelectric point (pI) of 7.3 to 7.4, the other with a pI of 4.6 to 4.7. Both forms of EP and LAF had m.w. of 13,000 to 16,000 daltons as judged by gel filtration. Both forms of EP had LAF activity, and both forms of LAF were pyrogenic. The pI 7.3 EP, which is known to have an -SH group essential for its biologic activity, bound to Thiol Sepharose columns and could be eluted with mercaptoethanol. The pI 7.3 LAF behaved in exactly the same way. Furthermore, antisera from three different goats were available that completely blocked the pyrogenicity of pI 7.3 EP in vivo; these sera also blocked the pI 7.3 LAF activity in vitro. The pI 4.6 EP and LAF did not bind to Thiol Sepharose columns, nor were they inhibited by any of the antisera that blocked the pI 7.3 EP and LAF. Moreover, isoelectric focusing of pI 4.6 EP in very shallow gradients revealed microheterogeneity with sharp peaks of EP activity observed at pH 4.6 and 4.7. Analysis for LAF activity showed an identical microheterogeneity. These results are consistent with the idea that EP and LAF are identical.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6965973

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  75 in total

1.  Central action sites of interleukin-1 beta for inducing fever in rabbits.

Authors:  N Murakami; Y Sakata; T Watanabe
Journal:  J Physiol       Date:  1990-09       Impact factor: 5.182

2.  P2X(7) receptor and macrophage function.

Authors:  Mark D Wewers; Anasuya Sarkar
Journal:  Purinergic Signal       Date:  2009-02-13       Impact factor: 3.765

Review 3.  Polyclonal activators in pulmonary immune disease.

Authors:  W F Willoughby; J B Willoughby; G F Gerberick
Journal:  Clin Rev Allergy       Date:  1985-05

4.  Expression of interleukin-1 in Reed-Sternberg cells and neoplastic cells from true histiocytic malignancies.

Authors:  S M Hsu; X Zhao
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

5.  Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis.

Authors:  J A Schmidt; C N Oliver; J L Lepe-Zuniga; I Green; I Gery
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

6.  Mechanism of prevention of postburn hypermetabolism and catabolism by early enteral feeding.

Authors:  H Mochizuki; O Trocki; L Dominioni; K A Brackett; S N Joffe; J W Alexander
Journal:  Ann Surg       Date:  1984-09       Impact factor: 12.969

7.  Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.

Authors:  P E Auron; A C Webb; L J Rosenwasser; S F Mucci; A Rich; S M Wolff; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

8.  Demonstration of interleukin 1 activity in apparently homogeneous specimens of the pI 5 form of rabbit endogenous pyrogen.

Authors:  D F Hanson; P A Murphy
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

9.  Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1a.

Authors:  Y Ozaki; T Ohashi; A Minami; S Nakamura
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

10.  Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization.

Authors:  P B Bitterman; S I Rennard; G W Hunninghake; R G Crystal
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.